{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:38:19Z","timestamp":1787564299392,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"CAMS Innovation Fund for Medical Sciences","award":["CIFMS"],"award-info":[{"award-number":["CIFMS"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2021-I2M-1-004"],"award-info":[{"award-number":["2021-I2M-1-004"]}]},{"name":"Special Research Fund for Central Universities, Peking Union Medical College","award":["3332023141"],"award-info":[{"award-number":["3332023141"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06822-7","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T04:51:59Z","timestamp":1754023919000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Novel triple-target panels utilizing methylation-sensitive restriction enzyme-based quantitative PCR for detecting advanced cervical precancers and cancers among high-risk HPV-positive women"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5289-1309","authenticated-orcid":false,"given":"Shimin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongshuang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tangjie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanghui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"issue":"3","key":"6822_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"6822_CR2","unstructured":"Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva: World Health Organization; 2020. https:\/\/iris.who.int\/bitstream\/handle\/10665\/336583\/9789240014107-eng.pdf?sequence=1. Accessed 17 Nov 2020."},{"key":"6822_CR3","unstructured":"WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition. Geneva: World Health Organization; 2021. https:\/\/iris.who.int\/bitstream\/handle\/10665\/342365\/9789240030824-eng.pdf?sequence=1 Accessed 7 Jul 2021."},{"key":"6822_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100293","volume":"22","author":"M Demarco","year":"2020","unstructured":"Demarco M, Hyun N, Carter-Pokras O, Raine-Bennett TR, Cheung L, Chen X, Hammer A, Campos N, Kinney W, Gage JC, et al. A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs. EClinicalMedicine. 2020;22: 100293.","journal-title":"EClinicalMedicine"},{"issue":"3","key":"6822_CR5","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ajog.2012.11.020","volume":"208","author":"JT Cox","year":"2013","unstructured":"Cox JT, Castle PE, Behrens CM, Sharma A, Wright TC Jr, Cuzick J. Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16\/18: results from the ATHENA HPV study. Am J Obstet Gynecol. 2013;208(3):184.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"6822_CR6","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/1471-0528.16395","volume":"128","author":"WW Kremer","year":"2021","unstructured":"Kremer WW, Steenbergen R, Heideman D, Kenter GG, Meijer C. The use of host cell DNA methylation analysis in the detection and management of women with advanced cervical intraepithelial neoplasia: a review. BJOG. 2021;128(3):504\u201314.","journal-title":"BJOG"},{"issue":"18","key":"6822_CR7","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.2217\/epi-2019-0331","volume":"12","author":"S Dick","year":"2020","unstructured":"Dick S, Verhoef L, De Strooper LM, Ciocanea-Teodorescu I, Wisman GBA, Meijer CJ, Bleeker MC, Steenbergen RD, Heideman DA. Evaluation of six methylation markers derived from genome-wide screens for detection of cervical precancer and cancer. Epigenomics. 2020;12(18):1569\u201378.","journal-title":"Epigenomics"},{"issue":"1","key":"6822_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13148-020-00885-7","volume":"12","author":"L Kong","year":"2020","unstructured":"Kong L, Wang L, Wang Z, Xiao X, You Y, Wu H, Wu M, Liu P, Li L. DNA methylation for cervical cancer screening: a training set in China. Clin Epigenetics. 2020;12(1):91.","journal-title":"Clin Epigenetics"},{"issue":"6","key":"6822_CR9","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/bjc.2014.392","volume":"111","author":"A Boers","year":"2014","unstructured":"Boers A, Bosgraaf RP, van Leeuwen RW, Schuuring E, Heideman DA, Massuger LF, Verhoef VM, Bulten J, Melchers WJ, van der Zee AG, et al. DNA methylation analysis in self-sampled brush material as a triage test in hrHPV-positive women. Br J Cancer. 2014;111(6):1095\u2013101.","journal-title":"Br J Cancer"},{"issue":"8","key":"6822_CR10","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1002\/ijc.26326","volume":"130","author":"JJ Eijsink","year":"2012","unstructured":"Eijsink JJ, Lendvai A, Deregowski V, Klip HG, Verpooten G, Dehaspe L, de Bock GH, Hollema H, van Criekinge W, Schuuring E, et al. A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients. Int J Cancer. 2012;130(8):1861\u20139.","journal-title":"Int J Cancer"},{"issue":"1","key":"6822_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12916-024-03267-5","volume":"22","author":"D Cao","year":"2024","unstructured":"Cao D, Yang Z, Dong S, Li Y, Mao Z, Lu Q, Xu P, Shao M, Pan L, Han X, et al. PCDHGB7 hypermethylation-based Cervical cancer Methylation (CerMe) detection for the triage of high-risk human papillomavirus-positive women: a prospective cohort study. BMC Med. 2024;22(1):55.","journal-title":"BMC Med"},{"issue":"1","key":"6822_CR12","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13148-015-0122-0","volume":"7","author":"PB Pun","year":"2015","unstructured":"Pun PB, Liao YP, Su PH, Wang HC, Chen YC, Hsu YW, Huang RL, Chang CC, Lai HC. Triage of high-risk human papillomavirus-positive women by methylated POU4F3. Clin Epigenetics. 2015;7(1):85.","journal-title":"Clin Epigenetics"},{"issue":"11","key":"6822_CR13","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.4161\/epi.26346","volume":"8","author":"SA Farkas","year":"2013","unstructured":"Farkas SA, Milutin-Gasperov N, Grce M, Nilsson TK. Genome-wide DNA methylation assay reveals novel candidate biomarker genes in cervical cancer. Epigenetics. 2013;8(11):1213\u201325.","journal-title":"Epigenetics"},{"issue":"6","key":"6822_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014297","volume":"98","author":"N Li","year":"2019","unstructured":"Li N, He Y, Mi P, Hu Y. ZNF582 methylation as a potential biomarker to predict cervical intraepithelial neoplasia type III\/worse: a meta-analysis of related studies in Chinese population. Medicine (Baltimore). 2019;98(6): e14297.","journal-title":"Medicine (Baltimore)"},{"key":"6822_CR15","first-page":"1882","volume":"101","author":"WH Ren","year":"2021","unstructured":"Ren WH, Zhao XL, Zhao FH. Global guidelines for cervical cancer screening: a systematic review. Zhonghua Yi Xue Za Zhi. 2021;101:1882\u20139.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"1","key":"6822_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13148-023-01537-2","volume":"15","author":"S Salta","year":"2023","unstructured":"Salta S, Lobo J, Magalhaes B, Henrique R, Jeronimo C. DNA methylation as a triage marker for colposcopy referral in HPV-based cervical cancer screening: a systematic review and meta-analysis. Clin Epigenetics. 2023;15(1):125.","journal-title":"Clin Epigenetics"},{"issue":"6","key":"6822_CR17","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nrc3728","volume":"14","author":"RD Steenbergen","year":"2014","unstructured":"Steenbergen RD, Snijders PJ, Heideman DA, Meijer CJ. Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions. Nat Rev Cancer. 2014;14(6):395\u2013405.","journal-title":"Nat Rev Cancer"},{"issue":"13","key":"6822_CR18","doi-asserted-by":"publisher","first-page":"E65","DOI":"10.1093\/nar\/29.13.e65","volume":"29","author":"C Grunau","year":"2001","unstructured":"Grunau C, Clark SJ, Rosenthal A. Bisulfite genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Res. 2001;29(13):E65-65.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"6822_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0199091","volume":"13","author":"S Kint","year":"2018","unstructured":"Kint S, De Spiegelaere W, De Kesel J, Vandekerckhove L, Van Criekinge W. Evaluation of bisulfite kits for DNA methylation profiling in terms of DNA fragmentation and DNA recovery using digital PCR. PLoS ONE. 2018;13(6): e0199091.","journal-title":"PLoS ONE"},{"key":"6822_CR20","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/978-1-4939-7481-8_21","volume":"1708","author":"G Beikircher","year":"2018","unstructured":"Beikircher G, Pulverer W, Hofner M, Noehammer C, Weinhaeusel A. Multiplexed and sensitive DNA methylation testing using methylation-sensitive restriction enzymes \u201cMSRE-qPCR.\u201d Methods Mol Biol. 2018;1708:407\u201324.","journal-title":"Methods Mol Biol"},{"issue":"12","key":"6822_CR21","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1002\/ijc.27571","volume":"131","author":"FH Zhao","year":"2012","unstructured":"Zhao FH, Lewkowitz AK, Hu SY, Chen F, Li LY, Zhang QM, Wu RF, Li CQ, Wei LH, Xu AD, et al. Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studies. Int J Cancer. 2012;131(12):2929\u201338.","journal-title":"Int J Cancer"},{"issue":"4","key":"6822_CR22","doi-asserted-by":"publisher","first-page":"663","DOI":"10.21147\/j.issn.1000-9604.2019.04.10","volume":"1","author":"S Zhao","year":"2019","unstructured":"Zhao S, Zhao X, Hu S, Lu J, Duan X, Zhang X, Chen F, Zhao F. Distribution of high-risk human papillomavirus genotype prevalence and attribution to cervical precancerous lesions in rural North China. Chin J Cancer Res. 2019;1(4):663\u201372.","journal-title":"Chin J Cancer Res"},{"issue":"6","key":"6822_CR23","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1001\/jama.2023.13174","volume":"330","author":"RB Perkins","year":"2023","unstructured":"Perkins RB, Wentzensen N, Guido RS, Schiffman M. Cervical cancer screening: a review. JAMA. 2023;330(6):547\u201358.","journal-title":"JAMA"},{"issue":"2","key":"6822_CR24","doi-asserted-by":"publisher","first-page":"118","DOI":"10.7326\/M15-2735","volume":"166","author":"M Arbyn","year":"2017","unstructured":"Arbyn M, Xu L, Verdoodt F, Cuzick J, Szarewski A, Belinson JL, Wentzensen N, Gage JC, Khan MJ. Genotyping for human papillomavirus types 16 and 18 in women with minor cervical lesions: a systematic review and meta-analysis. Ann Intern Med. 2017;166(2):118\u201327.","journal-title":"Ann Intern Med"},{"key":"6822_CR25","unstructured":"National Health Commission of the People\u2019s Republica of China. Cervical cancer screening work plan. 2021.http:\/\/www.nhc.gov.cn\/fys\/s3581\/202201\/cad44d88acca4ae49e12dab9176ae21c\/files\/7afa7269d02c4ba793b40561e8088c27.pdf. Accessed 1 Jan 2022."},{"issue":"3","key":"6822_CR26","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1002\/ijc.26056","volume":"130","author":"DC Rijkaart","year":"2012","unstructured":"Rijkaart DC, Berkhof J, van Kemenade FJ, Coupe VM, Hesselink AT, Rozendaal L, Heideman DA, Verheijen RH, Bulk S, Verweij WM, et al. Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening. Int J Cancer. 2012;130(3):602\u201310.","journal-title":"Int J Cancer"},{"issue":"7","key":"6822_CR27","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1080\/15592294.2018.1507197","volume":"13","author":"W Verlaat","year":"2018","unstructured":"Verlaat W, Van Leeuwen RW, Novianti PW, Schuuring E, Meijer C, Van Der Zee AGJ, Snijders PJF, Heideman DAM, Steenbergen RDM, Wisman GBA. Host-cell DNA methylation patterns during high-risk HPV-induced carcinogenesis reveal a heterogeneous nature of cervical pre-cancer. Epigenetics. 2018;13(7):769\u201378.","journal-title":"Epigenetics"},{"issue":"360","key":"6822_CR28","doi-asserted-by":"publisher","first-page":"k499","DOI":"10.1136\/bmj.k499","volume":"27","author":"K Tainio","year":"2018","unstructured":"Tainio K, Athanasiou A, Tikkinen KAO, Aaltonen R, C\u00e1rdenas J, Hern\u00e1ndes, Glazer-Livson S, Jakobsson M, Joronen K, Kiviharju M, Louvanto K, Oksjoki S, T\u00e4htinen R, Virtanen S, Nieminen P, Kyrgiou M, Kalliala I. Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis. BMJ. 2018;27(360):k499.","journal-title":"BMJ"},{"issue":"26","key":"6822_CR29","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1200\/JCO.21.02433","volume":"40","author":"WW Kremer","year":"2022","unstructured":"Kremer WW, Dick S, Heideman DAM, Steenbergen RDM, Bleeker MCG, Verhoeve HR, van Baal WM, van Trommel N, Kenter GG, Meijer CJLM, Berkhof J. Clinical regression of high-grade cervical intraepithelial neoplasia is associated with absence of FAM19A4\/miR124\u20132 DNA methylation (CONCERVE Study). J Clin Oncol. 2022;40(26):3037\u201346.","journal-title":"J Clin Oncol"},{"issue":"15","key":"6822_CR30","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.3390\/cancers15153951","volume":"15","author":"H Hoyer","year":"2023","unstructured":"Hoyer H, Stolte C, B\u00f6hmer G, Hampl M, Hagemann I, Maier E, Denecke A, Hirchenhain C, Patzke J, Jentschke M, Gerick A, Heller T, Hippe J, Wunsch K, Schmitz M, D\u00fcrst M. Evaluation of CIN2\/3 lesion regression in GynTect\u00ae\u00a0DNA methylation-marker-negative patients in a longitudinal study. Cancers (Basel). 2023;15(15):3951.","journal-title":"Cancers (Basel)"},{"issue":"12","key":"6822_CR31","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1093\/cid\/ciz677","volume":"70","author":"K Louvanto","year":"2020","unstructured":"Louvanto K, Aro K, Nedjai B, B\u00fctzow R, Jakobsson M, Kalliala I, Dillner J, Nieminen P, Lorincz A. Methylation in predicting progression of untreated high-grade cervical intraepithelial neoplasia. Clin Infect Dis. 2020;70(12):2582\u201390.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"6822_CR32","doi-asserted-by":"publisher","first-page":"9195","DOI":"10.1038\/s41598-019-45477-5","volume":"9","author":"PH Su","year":"2019","unstructured":"Su PH, Lai HC, Huang RL, Chen LY, Wang YC, Wu TI, Chan MWY, Liao CC, Chen CW, Lin WY, et al. Paired Box-1 (PAX1) activates multiple phosphatases and inhibits kinase cascades in cervical cancer. Sci Rep. 2019;9(1):9195.","journal-title":"Sci Rep"},{"issue":"10","key":"6822_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gni092","volume":"33","author":"AA Melnikov","year":"2005","unstructured":"Melnikov AA, Gartenhaus RB, Levenson AS, Motchoulskaia NA, Levenson Chernokhvostov VV. MSRE-PCR for analysis of gene-specific DNA methylation. Nucleic Acids Res. 2005;33(10): e93.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"6822_CR34","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1165\/rcmb.2019-0150TR","volume":"61","author":"BD Singer","year":"2019","unstructured":"Singer BD. A practical guide to the measurement and analysis of DNA methylation. Am J Respir Cell Mol Biol. 2019;61(4):417\u201328.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"6822_CR35","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.3390\/cimb43030100","volume":"43","author":"W Pulverer","year":"2021","unstructured":"Pulverer W, Kruusmaa K, Schonthaler S, Huber J, Bitenc M, Bachleitner-Hofmann T, Bhangu JS, Oehler R, Egger G, Weinhausel A. Multiplexed DNA methylation analysis in colorectal cancer using liquid biopsy and its diagnostic and predictive value. Curr Issues Mol Biol. 2021;43(3):1419\u201335.","journal-title":"Curr Issues Mol Biol"},{"key":"6822_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.774215","volume":"8","author":"J Yuan","year":"2021","unstructured":"Yuan J, Mao Z, Lu Q, Xu P, Wang C, Xu X, Zhou Z, Zhang T, Yu W, Dong S, et al. Hypermethylated PCDHGB7 as a biomarker for early detection of endometrial cancer in endometrial brush samples and cervical scrapings. Front Mol Biosci. 2021;8: 774215.","journal-title":"Front Mol Biosci"},{"issue":"6","key":"6822_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.457","volume":"11","author":"S Dong","year":"2021","unstructured":"Dong S, Lu Q, Xu P, Chen L, Duan X, Mao Z, Zhang B, Sui L, Wang Y, Yu W. Hypermethylated PCDHGB7 as a universal cancer only marker and its application in early cervical cancer screening. Clin Transl Med. 2021;11(6): e457.","journal-title":"Clin Transl Med"},{"issue":"2","key":"6822_CR38","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/ijc.33320","volume":"148","author":"J Bonde","year":"2021","unstructured":"Bonde J, Floore A, Ejegod D, Vink FJ, Hesselink A, van de Ven PM, Valencak AO, Pedersen H, Doorn S, Quint WG, et al. Methylation markers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirus screen positive women: a large European multicenter study. Int J Cancer. 2021;148(2):396\u2013405.","journal-title":"Int J Cancer"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06822-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06822-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06822-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T10:14:46Z","timestamp":1757326486000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06822-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6822"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06822-7","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"value":"8 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Participants who provided newly collected samples gave written informed consent. For the use of residual samples from previous studies, ethical committee approval was obtained to waive informed consent. This study was approved by the ethics committees of National Cancer Center\/Cancer Hospital, Chinese Academy of Medical Sciences (NCC\/CHCAMS) (Approval No. 22\/364-3566).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"H.D., T.G., M.C., X.Z.\u00a0(Zhou Xinghua), and L.D. are employees of Sansure Biotech Inc. H.D., T.G., and M.C. hold stock in Sansure Biotech Inc., while L.D. serves as the president of the company. The other co-authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"857"}}